HOUSTON, October 06, 2025--(BUSINESS WIRE)--SynergenX, veteran-owned leader in personalized hormone and wellness medicine, is expanding its peptide therapy program with the addition of BPC-157 and CJC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback